MET and alveolar rhabdomyosarcoma: ARMS not only has the presence of the PAX3/PAX7 and FOXO1 fusion genes, but also displays increased levels of MET, a receptor tyrosine kinase (RTK) known to be linked with the metastatic potential of RMS cells [15,18].